Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal
Paywall
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
Read the full article on Bloomberg
Read Full Article →